October 2017

Senate Finance Committee Chairman Orrin Hatch, along with 10 of his Republican Committee colleagues, recently called on the…

The distinct split between the Second and Fifth Circuit Courts’ interpretation as to when whistleblower protections are allowed…

Late last week, John N. Kapoor, the founder and majority owner of Insys Therapeutics, Inc., was arrested and charged with leading…

With the new administration, there appears to be a renewed commitment to enforcing anti-kickback rules against healthcare…

Aegerion recently finalized a $40.1 million settlement that resolves civil and criminal charges over its marketing of JUXTAPID®.…

In the September issue of the Life Science Compliance Update, the authors discussed the new Ohio drug distribution verification…

Earlier this year the U.S. House of Representatives passed a bipartisan bill, the Medicare Part B Improvement Act of 2017. The…

Under the Improper Payments Information Act of 2002, as amended, the Department of Health and Human Services (HHS) is required to…

Over the past two decades, the role that patients play in their health care has dramatically shifted. As a result, there is an…

On August 15, the Centers for Medicare & Medicaid Services (CMS) announced a proposed rule to reduce the number of mandatory…